Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
about
Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in JapanPandemic influenza: a never-ending story.From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.Strategies towards universal pandemic influenza vaccines.The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patientsPharmacokinetics of oseltamivir according to trimester of pregnancy.Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary.How to approach and treat viral infections in ICU patientsPharmacokinetics of oseltamivir among pregnant and nonpregnant women.Pharmacokinetics and diffusion into sputum of oseltamivir and oseltamivir carboxylate in adults with cystic fibrosis.Development of oseltamivir phosphonate congeners as anti-influenza agentsClinical and virologic outcomes in patients with oseltamivir-resistant seasonal influenza A (H1N1) infections: results from a clinical trial.Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.Extraction and Chromatographic Determination of Shikimic Acid in Chinese Conifer Needles with 1-Benzyl-3-methylimidazolium Bromide Ionic Liquid Aqueous Solutions.Therapeutic drug monitoring of anti-infective agents in critically ill patients.Transplacental transfer of oseltamivir phosphate and its metabolite oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population.Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.Oseltamivir pharmacokinetics in Mexican obese and non-obese healthy subjects and patients. Evidence for an absence of interethnic variability.ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.Antimicrobial AgentsCarboxylesterase 1 Polymorphism Impairs Oseltamivir Bioactivation in Humans
P2860
Q28545776-575EDFBF-47B7-4847-B36A-91414A1741EDQ30353560-5F9292B4-EFDC-42A9-97EC-499B8E57E73DQ30363724-90FBF5C0-A68F-4687-BCD6-5A6DE25E60F2Q30373969-C08E62FB-1468-4322-9D59-8795C377C7A7Q30382226-FA1BC6C2-B17A-4529-8739-1FB581C488E2Q30397216-6B64F671-8D54-47CF-ABF1-28014315577CQ30401840-D6FDD6F6-2702-49C0-9B51-1E23B7A9112BQ30407250-278F83D6-4983-4C47-AB34-0A8622E89825Q34894660-60DECE04-0725-4F33-A0B8-E9056D41DF07Q35036389-9951C172-1EDE-454A-8678-0E4AA674BAB8Q35191579-BFAA84BF-57B0-4E45-A896-5314C51CDAC9Q36382214-6C9EB9C6-C310-4355-94E0-CFCEC4AE4FAAQ37087113-532A7099-21EB-47B0-9388-C2EFEFC32342Q38084212-2215C5F1-AB9A-4BE9-8C3D-E74AA4716B6DQ38674948-A5A3064E-35EC-41DB-BC61-EE6F52EB2C45Q38790740-97CE8CAD-953D-40AA-B265-553D64600D34Q39592863-878416A6-721E-403F-A8B5-FDBAD5AAD63CQ40748977-B5B052DB-4403-4A1B-B8B3-4FAB29CD720FQ42318178-97481E86-960C-4825-90B7-8195744B0AC7Q48910582-317595FE-4B35-4F20-BB45-A04B700C0B58Q57549163-B9CD6504-2A74-41C1-8A55-A81EFF6C0138Q57825111-432AC8AA-4850-40E4-8221-73D586F8ED06
P2860
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Oseltamivir in seasonal, avian ...... armacodynamic characteristics.
@ast
Oseltamivir in seasonal, avian ...... armacodynamic characteristics.
@en
type
label
Oseltamivir in seasonal, avian ...... armacodynamic characteristics.
@ast
Oseltamivir in seasonal, avian ...... armacodynamic characteristics.
@en
prefLabel
Oseltamivir in seasonal, avian ...... armacodynamic characteristics.
@ast
Oseltamivir in seasonal, avian ...... armacodynamic characteristics.
@en
P2093
P2860
P921
P1476
Oseltamivir in seasonal, avian ...... harmacodynamic characteristics
@en
P2093
Anton Ivanyuk
Manel Aouri
Pascal Meylan
Thierry Buclin
P2860
P304
P356
10.2165/11534730-000000000-00000
P577
2010-11-01T00:00:00Z
P6179
1003074611